iNtRON Biotechnology, Inc. (KOSDAQ:A048530) announces a share repurchase program. Under the program, the company will repurchase up to KRW 3,000 million worth of its shares under the contract with Shinhan Investment & Securities. The purpose of the program is to enhance shareholder value.

The program will be valid till June 20, 2025. As of June 18, 2024, the company had 958,777 shares in treasury within scope available for dividend and had 438 shares in treasury through other repurchase.